PiB-PET used to explore brain changes

05/29/2013 | MedPage Today (free registration)

Buildup of beta-amyloid in the brain as measured through PiB-PET imaging appears to be linked to memory impairment and gray matter atrophy in cognitively normal adults, according to a subanalysis of the Australian Imaging, Biomarkers and Lifestyle Study of Aging published in JAMA Neurology. The results indicate PiB-PET imaging can be used to identify patients with cognitive impairment, according to the authors. "These findings support the notion that amyloid deposition is not a benign process and that interventions with anti-amyloid therapy at these early stages have a higher chance to be effective," researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC